|
90
|
270
|
4h05A |
Crystal structure of aminoglycoside-3'-phosphotransferase of type viii |
|
100
|
329
|
4gubA |
Casein kinase ii bound to inhibitor |
|
85
|
288
|
4gt4A |
Structure of unliganded, inactive ror2 kinase domain |
|
103
|
341
|
4gygA |
Crystal structure of the rio2 kinase from chaetomium thermophilum |
|
82
|
273
|
4gw8A |
Human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and leucettine l41 |
|
81
|
272
|
4h1jA |
Crystal structure of pyk2 with the pyrazole 13a |
|
92
|
273
|
4gu6A |
Focal adhesion kinase catalytic domain in complex with n-{3-[(5-cyano-2-phenyl-1h-pyrrolo[2,3-b]pyridin-4-ylamino)- methyl]-pyridin-2-yl}-n-methyl-methanesulfonamide |
|
83
|
299
|
4gueA |
Structure of n-terminal kinase domain of rsk2 with flavonoid glycoside quercitrin |
|
118
|
327
|
4grbA |
Casein kinase 2 (ck2) bound to inhibitor |
|
83
|
271
|
4h1mA |
Crystal structure of pyk2 with the indole 10c |
|
89
|
296
|
4gt5A |
Crystal structure of the inactive trka kinase domain |
|
106
|
341
|
4gyiA |
Crystal structure of the rio2 kinase-adp/mg2+-phosphoaspartate complex from chaetomium thermophilum |
|
83
|
272
|
4gu9A |
Focal adhesion kinase catalytic domain in complex with (2-fluoro-phenyl)-(1h-pyrazolo[3,4-d]pyrimidin-4-yl)-amine |
|
106
|
348
|
4gt3A |
Atp-bound form of the erk2 kinase |
|
93
|
307
|
4gs6A |
Irreversible inhibition of tak1 kinase by 5z-7-oxozeaenol |
|
112
|
346
|
4gvaA |
Adp-bound form of the erk2 kinase |
|
111
|
348
|
4gsbA |
Monoclinic crystal form of the apo-erk2 |
|
94
|
290
|
4gvjA |
Tyk2 (jh1) in complex with adenosine di-phosphate |
|
105
|
335
|
4gv1A |
Pkb alpha in complex with azd5363 |
|
91
|
277
|
4gfgA |
Crystal structure of spleen tyrosine kinase complexed with r9021 |
|
77
|
274
|
4g9rA |
B-raf v600e kinase domain bound to a type ii dihydroquinazoline inhibitor |
|
107
|
333
|
4g3fA |
Crystal structure of murine nf-kappab inducing kinase (nik) bound to a 2-(aminothiazoly)phenol (cmp2) |
|
87
|
295
|
4gk2A |
Human epha3 kinase domain in complex with ligand 66 |
|
97
|
291
|
4gfmA |
Jak2 kinase (jh1 domain) with 2,6-dichloro-n-(2-oxo-2,5-dihydropyridin-4-yl)benzamide |
|
99
|
362
|
4g6lA |
Crystal structure of human cdk8/cycc in the dmg-in conformation |
|
101
|
341
|
4g3dA |
Crystal structure of human nf-kappab inducing kinase (nik) |
|
90
|
295
|
4gk3A |
Human epha3 kinase domain in complex with ligand 87 |
|
88
|
288
|
4gj3A |
Tyk2 (jh1) in complex with 2,6-dichloro-4-cyano-n-[2-({[(1r,2r)-2-fluorocyclopropyl]carbonyl}amino)pyridin-4-yl]benzamide |
|
64
|
276
|
4g9cA |
Human b-raf kinase domain bound to a type ii pyrazolopyridine inhibitor |
|
104
|
333
|
4g3gA |
Crystal structure of murine nf-kappab inducing kinase (nik) v408l bound to a 2-(aminothiazolyl)phenol (cmp3) |
|
77
|
278
|
4gh2A |
Crystal structure of the chk1 |
|
89
|
304
|
4gcjA |
Cdk2 in complex with inhibitor rc-3-89 |
|
106
|
347
|
4g6oA |
Crystal structure of the erk2 |
|
111
|
342
|
4g3cA |
Crystal structure of apo murine nf-kappab inducing kinase (nik) |
|
109
|
348
|
4g6nA |
Crystal structure of the erk2 |
|
76
|
321
|
4g5pA |
Crystal structure of egfr kinase t790m in complex with bibw2992 |
|
87
|
289
|
4giiA |
Tyk2 (jh1) in complex with 2,6-dichloro-4-cyano-n-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}benzamide |
|
84
|
321
|
4g5jA |
Crystal structure of egfr kinase in complex with bibw2992 |
|
78
|
288
|
4gl9A |
Crystal structure of inhibitory protein socs3 in complex with jak2 kinase domain and fragment of gp130 intracellular domain |
|
109
|
347
|
4geoA |
P38a map kinase def-pocket penta mutant (m194a, l195a, h228a, i229a, y258a) |
|
92
|
300
|
4gmyA |
Jak2 kinase (jh1 domain) in complex with 2,6-dichloro-n-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}benzamide |
|
84
|
281
|
4gg5A |
Crystal structure of cmet in complex with novel inhibitor |
|
77
|
272
|
4gkiA |
Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor 1-nm-pp1 |
|
95
|
288
|
4gihA |
Tyk2 (jh1) in complex with 2,6-dichloro-n-{2-[(cyclopropylcarbonyl)amino]pyridin-4-yl}benzamide |
|
80
|
254
|
4gkhA |
Crystal structure of the aminoglycoside phosphotransferase aph(3')-ia, with substrate kanamycin and small molecule inhibitor 1-na-pp1 |
|
91
|
288
|
4gj2A |
Tyk2 (jh1) in complex with 2,6-dichloro-n-[2-({[(1r,2r)-2-fluorocyclopropyl]carbonyl}amino)pyridin-4-yl]benzamide |
|
84
|
289
|
4gfoA |
Tyk2 kinase (jh1 domain) with 2,6-dichloro-n-(2-oxo-2,5-dihydropyridin-4-yl)benzamide |
|
89
|
281
|
4gg7A |
Crystal structure of cmet in complex with novel inhibitor |
|
87
|
295
|
4gk4A |
Human epha3 kinase domain in complex with ligand 90 |
|
79
|
277
|
4ftiA |
Crystal structure of the chk1 |
